| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.2M | +181.4% |
| Cost of Revenue | $19.1M | +85.8% |
| Gross Profit | $1.0M | +132.3% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $10.4M | -25.8% |
| Operating Income | -$57K | +99.5% |
| Pre-tax Income | -$4.5M | +61.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$9.5M | +88.3% |
| EPS (Basic) | -$0.32 | +88.6% |
| EPS (Diluted) | -$0.32 | +88.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | -26.9% |
| Accounts Receivable | $7.9M | -30.6% |
| Inventory | $1.8M | -58.2% |
| Current Assets | $25.6M | -44.7% |
| Total Assets | $28.6M | -46.9% |
| Current Liabilities | $12.4M | -34.3% |
| Long-term Debt | $32.6M | -5.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.7M | +49.8% |
| Capital Expenditures | $112K | -48.9% |
| Investing Cash Flow | $22.1M | -62.2% |
| Financing Cash Flow | -$2.9M | -8.5% |
| Free Cash Flow | -$31.8M | +49.8% |
| Total Liabilities |
| $40.2M |
| -26.6% |
| Stockholders' Equity | -$11.6M | -1218.8% |